Market access barriers

This report outlines key barriers that prevent biosimilar and generic medicines from reaching patients even after regulatory approval.

This report outlines key barriers that prevent biosimilar and generic medicines from reaching patients even after regulatory approval.

This video from STAT breaks down what happens to prescription drug prices after patents expire.